West Pharmaceutical Services Inc financial data

Symbol
WST on NYSE
Location
530 Herman O. West Drive, Exton, PA
State of incorporation
PA
Fiscal year end
December 31
Former names
WEST CO INC (to 2/11/1999)
Latest financial report
10-K - Q4 2024 - Feb 18, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 267 % -22.2%
Quick Ratio 69.3 % -11.5%
Debt-to-equity 34.8 % +5.81%
Return On Assets 13.7 % -13.7%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 72.3M shares -1.36%
Common Stock, Shares, Outstanding 72.3M shares -1.63%
Entity Public Float 23.9B USD -15.2%
Common Stock, Value, Issued 18.8M USD 0%
Weighted Average Number of Shares Outstanding, Basic 73M shares -1.75%
Weighted Average Number of Shares Outstanding, Diluted 73.7M shares -2.13%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 2.89B USD -1.92%
Research and Development Expense 69.1M USD +1.02%
Operating Income (Loss) 570M USD -15.7%
Nonoperating Income (Expense) 17.6M USD +28.5%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 165M USD -12%
Income Tax Expense (Benefit) 108M USD -12.1%
Net Income (Loss) Attributable to Parent 493M USD -17%
Earnings Per Share, Basic 6.75 USD/shares -15.4%
Earnings Per Share, Diluted 6.69 USD/shares -15.1%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 485M USD -43.2%
Accounts Receivable, after Allowance for Credit Loss, Current 553M USD +7.91%
Inventory, Net 377M USD -13.3%
Other Assets, Current 124M USD -8.69%
Assets, Current 1.54B USD -20.6%
Deferred Income Tax Assets, Net 26M USD +1.17%
Property, Plant and Equipment, Net 1.58B USD +11.9%
Operating Lease, Right-of-Use Asset 105M USD +5.34%
Intangible Assets, Net (Excluding Goodwill) 10.8M USD -28.5%
Goodwill 106M USD -2.3%
Other Assets, Noncurrent 74.3M USD +249%
Assets 3.64B USD -4.86%
Accounts Payable, Current 239M USD -1.28%
Liabilities, Current 550M USD -18.1%
Deferred Income Tax Liabilities, Net 20.5M USD +61.4%
Operating Lease, Liability, Noncurrent 81.8M USD -3.2%
Other Liabilities, Noncurrent 62.2M USD +6.33%
Liabilities 961M USD +1.33%
Accumulated Other Comprehensive Income (Loss), Net of Tax -258M USD -79.5%
Retained Earnings (Accumulated Deficit) 3.96B USD +12.3%
Stockholders' Equity Attributable to Parent 2.68B USD -6.9%
Liabilities and Equity 3.64B USD -4.86%

Popular Metrics

Label TTM Value / Value Unit Change %
Common Stock, Shares Authorized 200M shares 0%
Common Stock, Shares, Issued 75.3M shares 0%
Common Stock, Par or Stated Value Per Share 0.25 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 485M USD -43.2%
Deferred Tax Assets, Valuation Allowance 12.8M USD -17.4%
Operating Lease, Liability 99.7M USD -2.45%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent 378M USD -40.2%
Lessee, Operating Lease, Liability, to be Paid 113M USD -4.23%
Property, Plant and Equipment, Gross 2.99B USD +9.05%
Operating Lease, Liability, Current 17.9M USD +1.13%
Lessee, Operating Lease, Liability, to be Paid, Year Two 20.7M USD +31.8%
Lessee, Operating Lease, Liability, to be Paid, Year One 23.4M USD +25.1%
Operating Lease, Weighted Average Discount Rate, Percent 0.04 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 13.4M USD -15.7%
Lessee, Operating Lease, Liability, to be Paid, Year Three 16.3M USD +45.5%
Deferred Tax Assets, Operating Loss Carryforwards 6.1M USD -39%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 3M shares 0%
Unrecognized Tax Benefits 43.6M USD +12.4%
Lessee, Operating Lease, Liability, to be Paid, Year Four 14.9M USD +56.8%
Operating Lease, Payments 29.5M USD +74.6%
Additional Paid in Capital 22.1M USD -81.6%
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance 93.8M USD -4.48%
Share-based Payment Arrangement, Expense 18.7M USD -19.7%
Interest Expense 700K USD -75.9%